Companies: 10,795·Total market cap: $144.5T
Aspira Women's Health Inc.

Aspira Women's Health Inc.

AWHNASDAQHealthcare
$0.08
$-0.02(-15.90%)
Market Cap$2458610
P/E Ratio
52W High$3.63
52W Low$0.08

Aspira Women's Health Inc. (AWH) Stock Ownership

Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.

SEC 13F · FMP · AWH · as of Mar 31, 2025

Ownership Breakdown

Institutions 2.88%
Insiders 30.13%
Public 66.98%

23

Institutional Holders

▼ 3 vs Q4

$81,009

Total Inst. Value

▼ $946,547 vs Q4

29.98M

Shares Outstanding

freeFloat 69.87%

864,082

13F Shares Held

▼ 592,958 vs Q4

Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.

Top Institutional Holders

AWH largest shareholders · institutional ownership

Q1 2025 · SEC 13F

Showing top 10 holders

HolderShares% OwnedWeightValueReportedChange

HRT FINANCIAL LP

in vitro & in vivo diagnostic substances

182.3K84.43%

84.43%

$17.00MMay 15, 2025NEW

GEODE CAPITAL MANAGEMENT, LLC

in vitro & in vivo diagnostic substances

132.0K61.12%

61.12%

$12.39MMay 13, 2025 33.9K

BLACKROCK, INC.

in vitro & in vivo diagnostic substances

82.2K38.09%

38.09%

$7.72MMay 2, 2025 535

VANGUARD GROUP INC

in vitro & in vivo diagnostic substances

79.2K36.67%

36.67%

$7.44MMay 9, 2025 194.9K

BANK OF AMERICA CORP /DE/

in vitro & in vivo diagnostic substances

63.5K29.42%

29.42%

$5.91MMay 15, 2025 5.2K

XTX TOPCO LTD

in vitro & in vivo diagnostic substances

62.2K28.80%

28.80%

$5.84MMay 8, 2025 62.2K

VIRTU FINANCIAL LLC

in vitro & in vivo diagnostic substances

52.9K24.48%

24.48%

$5.00MMay 12, 2025 40.5K

PINE VALLEY INVESTMENTS LTD LIABILITY CO

in vitro & in vivo diagnostic substances

33.4K23.63%

23.63%

$3.14MFeb 17, 2026— held

UBS GROUP AG

in vitro & in vivo diagnostic substances

34.2K15.84%

15.84%

$3.21MMay 13, 2025 32.2K

TWO SIGMA SECURITIES, LLC

in vitro & in vivo diagnostic substances

29.8K13.81%

13.81%

$2.80MMay 15, 2025 8.3K

Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).

Institutional Activity

Q1 2025 vs prior quarter

Q1 2025

Net institutional sentimentBullish — more buying than selling

10

Increased

+193.6K shares

1

New Positions

first time holders

5

Decreased

−207.5K shares

5

Sold Out

fully exited

Net shares change (top 50)

13.8K

+193.6K / −207.5K

Net new holders

+1

1 new / 5 exited

Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).

Insider Buying vs Selling

AWH insider trading · insider activity

Source: SEC Form 4

0

Buy transactions

0

Sell transactions

0.00

Buy/Sell ratio

$0M

Total disposed

Recent Insider Transactions

Showing 10 most recent · Common Stock only

Name · RoleDateTypeSharesPriceValueAfter Trans.Filing

Buhle Michael William

Chief Executive Officer

May 22, 2025Award100,000$0.07$7.0K100.0KForm 4 ↗

Beausang Ellen

director

Mar 11, 2025Award6,4586.5KForm 4 ↗

Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.

About institutional & insider ownership

Aspira Women's Health Inc. (AWH) is primarily owned by institutional investors, who hold approximately 2.9% of total shares outstanding. Company insiders own approximately 30.13%, while retail and public investors account for the remaining 66.98%.

The largest institutional shareholder of Aspira Women's Health Inc. is HRT FINANCIAL LP, holding approximately 182,286 shares — equal to 84.43% of outstanding shares — as of March 31, 2025.

A total of 23 institutional investors currently hold AWH stock, with a combined institutional value of approximately $81,009 as of the most recent 13F filing period.

Frequently asked questions

AWH ownership

Aspira Women's Health Inc. (AWH) is primarily owned by institutional investors, who hold approximately 2.9% of shares. The largest shareholder is HRT FINANCIAL LP with a 84.43% stake. Company insiders hold 30.13%. Data sourced from SEC Form 13F as of March 31, 2025.

who owns AWH stockAWH ownership structureSEC Form 13F institutional holdingsAWH float vs institutions
Source: FMP · SEC Form 13F · SEC Form 4As of March 31, 2025